# Jiangsu Zecen Biotech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jiangsu-zecen-biotech-co

- Industry: Medical Devices & Equipment
- Headquarters: Taizhou, China
- Website: www.zechengbio.com
- Total disclosed funding: $26M
- Latest round: Series C (Jul 30, 2019)
- Investors on record: 13

## About

Established in 2011 and based in Jiangyin, China, Jiangsu Zecen Biotech Co., Ltd. is an in vitro medical device developer that focuses on development, manufacturing and marketing of in vitro diagnostic reagents and instruments. The company is headquartered in Taizhou and has branches in Weifang, Xi'an and Hefei.

The company’s main business is ??delivering fully automated chemiluminescence solutions for in vitro diagnostics (IVD)??, specializing in the R&D, production, and sales of high-precision immunoassay systems and reagents. The company’s self-developed products include ??CIA2800 automated chemiluminescence analyzers??, ??magnetic particle-based chemiluminescent diagnostic kits??, and ??POCT-oriented chemiluminescence platforms?? for rapid on-site diagnostics. Its products are used in the fields of ??clinical laboratories??, ??public health screening??, and ??precision medicine??.

The company generates revenue by ??selling chemiluminescence analyzers and reagents to hospitals and diagnostic centers, licensing patented technologies, and providing CDMO services for global IVD brands??.

## Funding rounds

- Series C, Jul 30, 2019, $26M — Hongtai Aplus, Jinkong Qiyuan Capital
- Series B, Jun 24, 2016 — TFTR Investment, Coastal Capital, Bauhinia Huifu Capital, Satisde Capital, Beijing Hetang International Healthcare Venture Investment Management, ZGB Investment, Beijing Borui Chenyu Investment Management, Taizhou China Medicine Chengrong Jianda Venture Investment, Shanghai Chuyuan Bojin Investment, Shanghai Aihe Business Consulting
- Series B, Dec 31, 2014 — SOHO Investment Group

## Investors

- SOHO Investment Group (https://capitalatlas.ai/funds/soho-investment-group) — Series B
- TFTR Investment (https://capitalatlas.ai/funds/tftr-investment) — Series B
- Coastal Capital (https://capitalatlas.ai/funds/coastal-capital) — Series B
- Bauhinia Huifu Capital (https://capitalatlas.ai/funds/bauhinia-huifu-capital) — Series B
- Satisde Capital (https://capitalatlas.ai/funds/satisde-capital) — Series B
- Beijing Hetang International Healthcare Venture Investment Management — Series B
- ZGB Investment — Series B
- Beijing Borui Chenyu Investment Management — Series B
- Taizhou China Medicine Chengrong Jianda Venture Investment — Series B
- Shanghai Chuyuan Bojin Investment — Series B
- Shanghai Aihe Business Consulting — Series B
- Hongtai Aplus (https://capitalatlas.ai/funds/hongtai-aplus) — Series C
- Jinkong Qiyuan Capital (https://capitalatlas.ai/funds/jinkong-qiyuan-capital) — Series C